Cytokine Assay for Early Identification of Pediatric Stem Cell Transplant Recipients

The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 2010 by Stanford University.
Recruitment status was  Recruiting
Information provided by:
Stanford University Identifier:
First received: June 1, 2010
Last updated: June 15, 2010
Last verified: June 2010
The aim of our study is to determine whether a clinically relevant laboratory measurement (of seven specific immunologic biochemicals in the blood) can identify which bone marrow transplant recipients are likely to progress to respiratory failure. Our ultimate goal is to devise a comprehensive and inclusive laboratory test that is effective at determining who is likely to go on to respiratory failure, in order to facilitate early medical intervention.

Stem Cell Transplantation
Blood and Marrow Transplant (BMT)

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Cytokine Assay for Early Identification of Pediatric Stem Cell Transplant Recipients at Risk for Respiratory Failure

Further study details as provided by Stanford University:

Biospecimen Retention:   Samples With DNA

Estimated Enrollment: 50
Study Start Date: July 2008
Estimated Study Completion Date: July 2011
Estimated Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)

Ages Eligible for Study:   up to 21 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Hematopoietic stem cell transplantation (HSCT) for any indication.

Inclusion Criteria:- Hematopoietic stem cell transplantation (HSCT) for any indication.

  • Patients will range from age 0 to age 21. There is no gender restriction. We expect the male to female ratio to end up being about 50/50
  • Ability to understand and the willingness to sign a written informed consent document.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01135355

Contact: Kimberly Boynton (650) 498-6713

United States, California
Stanford University School of Medicine Recruiting
Stanford, California, United States, 94305
Contact: Kimberly Boynton    650-498-6713   
Contact: Cancer Clinical Trials Office    (650) 498-7061      
Principal Investigator: Rajni Agarwal-Hashmi         
Sub-Investigator: Steven R. Alexander         
Sub-Investigator: Joseph V. Dicarlo         
Sponsors and Collaborators
Stanford University
Principal Investigator: Rajni Agarwal-Hashmi Stanford University
  More Information

No publications provided

Responsible Party: Rajni Agarwal-Hashmi, Stanford University School of Medicine Identifier: NCT01135355     History of Changes
Other Study ID Numbers: SU-09222008-1301, PEDSBMT199, PEDSHSCT0002
Study First Received: June 1, 2010
Last Updated: June 15, 2010
Health Authority: United States: Institutional Review Board processed this record on November 25, 2015